Aboulaye Meïté
Biographic Data
| ID | 7028828 |
|---|---|
| NAME | Aboulaye Meïté |
| GIVEN NAMES | Aboulaye |
| FAMILY NAME | Meïté |
| SIGNATURE | MEÏTÉ A |
| AFFILIATIONS | Ministère de la Santé et de l'Hygiène Publique |
| ORCID | 0000-0001-7701-6551 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2014 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Feasibility and acceptability of integrating mass distribution of azithromycin to children 1–11 months into a trachoma mass drug administration campaign to reduce child mortality in Côte d’Ivoire
Evidence suggests that bi-annual mass drug administration (MDA) of single-dose azithromycin to 1–11 month-old children reduces child mortality in high child-mortality settings. Several countries conduct annual MDAs to distribute azithromycin to individuals ages 6 months and older to prevent trachoma infection. This study examined the feasibility and acceptability of reaching 1–11 months-old children during a trachoma MDA in Côte d’Ivoire by exten…
How well do coverage surveys and programmatically reported mass drug administration coverage match? Results from 214 mass drug administration campaigns in 15 countries, 2008–2017
INTRODUCTION: Delivering preventive chemotherapy through mass drug administration (MDA) is a central approach in controlling or eliminating several neglected tropical diseases (NTDs). Treatment coverage, a primary indicator of MDA performance, can be measured through routinely reported programmatic data or population-based coverage evaluation surveys. Reported coverage is often the easiest and least expensive way to estimate coverage; however, it…
Effectiveness of community-based burden estimation to achieve elimination of lymphatic filariasis
For lymphatic filariasis (LF) elimination, endemic countries must document the burden of LF morbidity (LFM). Community-based screening (CBS) is used to collect morbidity data, but evidence demonstrating its reliability is limited. Recent pilots of CBS for LFM alongside mass drug administration (MDA) in Côte d’Ivoire suggested low LFM prevalence (2.1–2.2 per 10,000). We estimated LFM prevalence in Bongouanou District, Côte d’Ivoire, using a compar…
Interrupting seasonal transmission of Schistosoma haematobium and control of soil-transmitted helminthiasis in northern and central Côte d’Ivoire
ISRCTN ISRCTN10926858 . Registered 21 December 2016. Retrospectively registered
Sustaining control of schistosomiasis mansoni in moderate endemicity areas in western Côte d’Ivoire
ISRCTN99401114 (date assigned: 12 November 2014)
No prominent works on this page.
Sustaining control of schistosomiasis mansoni in moderate endemicity areas in western Côte d’Ivoire
ISRCTN99401114 (date assigned: 12 November 2014)
Interrupting seasonal transmission of Schistosoma haematobium and control of soil-transmitted helminthiasis in northern and central Côte d’Ivoire
ISRCTN ISRCTN10926858 . Registered 21 December 2016. Retrospectively registered
Effectiveness of community-based burden estimation to achieve elimination of lymphatic filariasis
For lymphatic filariasis (LF) elimination, endemic countries must document the burden of LF morbidity (LFM). Community-based screening (CBS) is used to collect morbidity data, but evidence demonstrating its reliability is limited. Recent pilots of CBS for LFM alongside mass drug administration (MDA) in Côte d’Ivoire suggested low LFM prevalence (2.1–2.2 per 10,000). We estimated LFM prevalence in Bongouanou District, Côte d’Ivoire, using a compar…
How well do coverage surveys and programmatically reported mass drug administration coverage match? Results from 214 mass drug administration campaigns in 15 countries, 2008–2017
INTRODUCTION: Delivering preventive chemotherapy through mass drug administration (MDA) is a central approach in controlling or eliminating several neglected tropical diseases (NTDs). Treatment coverage, a primary indicator of MDA performance, can be measured through routinely reported programmatic data or population-based coverage evaluation surveys. Reported coverage is often the easiest and least expensive way to estimate coverage; however, it…
Feasibility and acceptability of integrating mass distribution of azithromycin to children 1–11 months into a trachoma mass drug administration campaign to reduce child mortality in Côte d’Ivoire
Evidence suggests that bi-annual mass drug administration (MDA) of single-dose azithromycin to 1–11 month-old children reduces child mortality in high child-mortality settings. Several countries conduct annual MDAs to distribute azithromycin to individuals ages 6 months and older to prevent trachoma infection. This study examined the feasibility and acceptability of reaching 1–11 months-old children during a trachoma MDA in Côte d’Ivoire by exten…
Environmental health (4 works) · Medicine (4 works) · Parasites and Host Interactions (4 works) · Helminths (3 works) · Immunology (3 works) · Pathology (3 works) · Public health (3 works) · Economics (2 works) · Global Maternal and Child Health (2 works) · Neglected tropical diseases (2 works)